Position statements and submissions

AstraZeneca is a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. We are committed to using our voice to contribute to important topics and create positive change.

2026-27 Pre-Budget Submission

Submission - March 2026

790KB

Out From the (BRCA) Shadows – The Reality of Living with a Hereditary Form of Metastatic Breast Cancer

Report - July 2025

843KB

2025-26 Pre-Budget Submission

Submission - February 2025

927KB

Out From the Shadows - The Reality of Living with Metastatic Breast Cancer

Report - August 2024

3,175KB

An Interim Cancer Fund in New Zealand

Green Paper - June 2024

2,701KB

An Interim Cancer Fund in Australia

Green Paper - March 2024

7,151KB

Supporting Document - March 2024

2,831KB

Use of genetic testing results in life insurance underwriting

Submission - January 2024

203KB

2024-25 Federal Pre-Budget Submission

Submission - January 2024

163KB

House of Representatives Standing Committee on Health, Aged Care and Sport’s Inquiry into Diabetes

Submission - August 2023

191KB

Senate Inquiry into rare and less common cancers, including neuroendocrine cancer

Submission - August 2023

210KB

Health Technology Assessment Review - Consultation No.1

Submission - June 2023

423KB

Inquiry into Developing Advanced Manufacturing in Australia

Submission - April 2023

145KB

2023-24 Federal Pre-Budget Submission

Submission - January 2023

235KB

Australian Cancer Plan

Position - December 2022

208KB

Inquiry into Long COVID and Repeated COVID Infections

Submission - November 2022

227KB

Supplementary Submission - February 2023

153KB

Reconciliation Action Plan

Action Plan - September 2022

54,195KB